SCHEMBL10544271

SCHEMBL10544271

O=C(Cc1cc2ccccc2[nH]1)Cc1ncc[nH]1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.43
IDO1 P14902 4/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MIF P14174 1/20 0.40
GSK3B P49841 1/20 0.40
PIN1 Q13526 1/20 0.39
AKR1B1 P15121 1/20 0.39
FLT3 P36888 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6758056 0.80 TAAR1 (0.51) LOXL2
SCHEMBL7738327 0.78 AKR1B1 (0.38) NLRP3IDO1LOXL2GAASMN1; SMN2
SCHEMBL8519473 0.76 TBXAS1 (0.50) GAASMN1; SMN2KDM4EHTT
SCHEMBL7731325 0.75 TBXAS1 (0.35) IDO1LOXL2SMN1; SMN2MIFGSK3B
SCHEMBL27736989 0.74 MTNR1A (0.54) NLRP3IDO1MTNR1AMTNR1BLOXL2
SCHEMBL3451201 0.73 LOXL2 (0.58) NLRP3IDO1MTNR1AMTNR1BLOXL2
SCHEMBL28935948 0.73 LOXL2 (0.50) NLRP3IDO1MTNR1AMTNR1BLOXL2
SCHEMBL28762418 0.73 NLRP3 (0.53) NLRP3IDO1MTNR1AMTNR1BLOXL2
SCHEMBL29365671 0.72 LOXL2 (0.56) NLRP3IDO1MTNR1AMTNR1BLOXL2
SCHEMBL49270 0.72 LOXL2 (0.56) NLRP3IDO1MTNR1AMTNR1BLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4808581-A ANXIOLYTIC, ANTIEMETIC, TREATMENT OF PSYCHOLOGICAL DISORDERS GLAXO GROUP LIMITED (GB) 1989-02-28 US disclosed